• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Sparfosic Acid

CAS No. 51321-79-0

Sparfosic Acid ( —— )

产品货号. M34033 CAS No. 51321-79-0

Sparfosic acid 是 DNA 抗代谢剂和天门冬氨酸氨甲酰转移酶 (aspartate transcarbamoyl transferase) 的有效抑制剂。Sparfosic acid 具有抗肿瘤活性。天冬氨酸氨甲酰转移酶催化第二步 de novo 嘧啶生物合成。Sparfosic acid 协同增强 5-氟尿嘧啶 (5-FU) 和干扰素-α (IFN) 对人结肠癌细胞系的细胞毒性。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥2946 有现货
5MG ¥4643 有现货
10MG ¥6646 有现货
25MG ¥9853 有现货
50MG ¥12747 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Sparfosic Acid
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Sparfosic acid 是 DNA 抗代谢剂和天门冬氨酸氨甲酰转移酶 (aspartate transcarbamoyl transferase) 的有效抑制剂。Sparfosic acid 具有抗肿瘤活性。天冬氨酸氨甲酰转移酶催化第二步 de novo 嘧啶生物合成。Sparfosic acid 协同增强 5-氟尿嘧啶 (5-FU) 和干扰素-α (IFN) 对人结肠癌细胞系的细胞毒性。
  • 产品描述
    Sparfosic acid, a DNA antimetabolite agent, is a potent inhibitor of aspartate transcarbamoyl transferase, the enzyme catalyzing the second step of de novo pyrimidine biosynthesis. Sparfosic acid synergistically enhances the cytotoxicity of a combination of 5-fluorouracil (5-FU) and interferon-alpha (IFN) against human colon cancer cell lines.
  • 体外实验
    Sparfosic acid (N-(Phosphonacetyl)-L-aspartate, PALA) causes apoptosis in the resistant Br1 cells.Sparfosic acid (300 μM) shows progressive accumulation of cells in S phase and activation of an apoptotic pathway leading to cell death.:Cell Viability Assay Cell Line:Br-l and L-2 cell lines established from metastasis in nude mouse injected with the human tumor cell line MDA-MB-435 Concentration:300 μM Incubation Time:12, 24 and 48 hours Result:Cells were predominantly in S phase in both the cell lines, although slightly higher proportion of cells in S phase were noted in L-2 than Brl-3prl cells.Western Blot Analysis Cell Line:Br-l and L-2 cell lines Concentration:300 μM Incubation Time:4, 10 and 24 hours Result:There was moderate difference in the level of phosphorylated Rb proteins seen in the two cell types.Marked increase in the amount of cyclin A protein was detected in the L-2 cells undergoing apoptosis with the highest level detected at 10 h post-drug treatment.In contrast, there was no increase in the level of cyclin A seen in the Brl-3prl cells.Cyclin E protein was found elevated in the L-2 cells and Brl-3prl cells compared to their respective controls.
  • 体内实验
    Sparfosic acid (490 mg/kg; i.p.; on days 1, 5, and 9; mice bearing B16 melanoma) shows the life-span is increased survives 77 to 86% longer than controls. Lewis lung carcinoma is highly sensitive to Sparfosic acid. Treatment on days 1, 5, and 9 following s.c. implantation of Lewis lung carcinoma is curative to 50% of the mice.
  • 同义词
    ——
  • 通路
    Apoptosis
  • 靶点
    Apoptosis
  • 受体
    Apoptosis
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    51321-79-0
  • 分子量
    255.12
  • 分子式
    C6H10NO8P
  • 纯度
    >98% (HPLC)
  • 溶解度
    In Vitro:?H2O 中的溶解度 : 125 mg/mL (489.97 mM; 超声助溶)
  • SMILES
    [C@H](NC(CP(=O)(O)O)=O)(CC(O)=O)C(O)=O
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Wang J, et al. Elevated cyclin A associated kinase activity promotes sensitivity of metastatic human cancer cells to DNA antimetabolite drug. Int J Oncol. 2015 Aug;47(2):782-90.?
产品手册
关联产品
  • ACBI1

    ACBI1 是 BAF ATPase 亚基 SMARCA2 和 SMARCA4 的有效 PROTAC 降解剂,还可降解多溴相关 BAF (PBAF) 复合体成员 PBRM1,MV-4-中 SMARCA2、SMARCA4 和 PBRM1 的 DC50 分别为 6 nM、11 nM 和 32 nM分别为 11 个单元。

  • Atrosab

    Atrosab 是一种人源化 IgG1 拮抗性抗 TNFR1 抗体。Atrosab 抑制 TNF 介导的细胞凋亡 (apoptosis) 以及 IL-6 和 IL-8 的产生。Atrosab 可用于炎症性疾病的研究。

  • Simmiparib

    Simmiparib 是一种高效且具有口服活性的 PARP1 和 PARP2 抑制剂,IC50 分别为 1.75 nM 和 0.22 nM。Simmiparib 对 PARP1/2 的抑制作用强于其母体化合物 Olaparib (HY-10162)。在同源重组修复 (HR) 缺陷细胞中,Simmiparib 诱导 DNA 双链断裂 (DSB) 积累和 G2/M 阻滞,从而诱导细胞凋亡 (apoptosis)。Simmiparib 在细胞和裸鼠移植瘤模型中都表现出显著的抗癌活性。